Home
Database Statistics
Help System
About
Literature
Projects
Events
Login / Register
Corrigendum: 7-Step Flow Synthesis of the HIV Integrase Inhibitor Dolutegravir.
2018
Robert E Ziegler, and Bimbisar K Desai, and Jo-Ann Jee, and B Frank Gupton, and Thomas D Roper, and Timothy F Jamison
Associated MeSH Terms
Cite
UI
MeSH Term
Description
Entries
Related Publications
Robert E Ziegler, and Bimbisar K Desai, and Jo-Ann Jee, and B Frank Gupton, and Thomas D Roper, and Timothy F Jamison
Dolutegravir, an HIV integrase inhibitor for the treatment of HIV infection.
January 2014, Drugs of today (Barcelona, Spain : 1998),
Robert E Ziegler, and Bimbisar K Desai, and Jo-Ann Jee, and B Frank Gupton, and Thomas D Roper, and Timothy F Jamison
[Integrase inhibitor in HIV therapy. Does dolutegravir set new standards?].
June 2014, MMW Fortschritte der Medizin,
Robert E Ziegler, and Bimbisar K Desai, and Jo-Ann Jee, and B Frank Gupton, and Thomas D Roper, and Timothy F Jamison
Dolutegravir: a new integrase strand transfer inhibitor for the treatment of HIV.
May 2014, Pharmacotherapy,
Robert E Ziegler, and Bimbisar K Desai, and Jo-Ann Jee, and B Frank Gupton, and Thomas D Roper, and Timothy F Jamison
Dolutegravir: a next-generation integrase inhibitor for treatment of HIV infection.
July 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Robert E Ziegler, and Bimbisar K Desai, and Jo-Ann Jee, and B Frank Gupton, and Thomas D Roper, and Timothy F Jamison
Dolutegravir, a second-generation integrase inhibitor for the treatment of HIV-1 infection.
March 2014, The Annals of pharmacotherapy,
Robert E Ziegler, and Bimbisar K Desai, and Jo-Ann Jee, and B Frank Gupton, and Thomas D Roper, and Timothy F Jamison
CYP1A1 and 1B1-mediated metabolic pathways of dolutegravir, an HIV integrase inhibitor.
December 2018, Biochemical pharmacology,
Robert E Ziegler, and Bimbisar K Desai, and Jo-Ann Jee, and B Frank Gupton, and Thomas D Roper, and Timothy F Jamison
Biochemical activity of RAGs is impeded by Dolutegravir, an HIV integrase inhibitor.
January 2020, Cell death discovery,
Robert E Ziegler, and Bimbisar K Desai, and Jo-Ann Jee, and B Frank Gupton, and Thomas D Roper, and Timothy F Jamison
Metabolism, excretion, and mass balance of the HIV-1 integrase inhibitor dolutegravir in humans.
August 2013, Antimicrobial agents and chemotherapy,
Robert E Ziegler, and Bimbisar K Desai, and Jo-Ann Jee, and B Frank Gupton, and Thomas D Roper, and Timothy F Jamison
Dolutegravir: a new integrase strand transfer inhibitor for the treatment of HIV - an alternative viewpoint.
September 2014, Pharmacotherapy,
Robert E Ziegler, and Bimbisar K Desai, and Jo-Ann Jee, and B Frank Gupton, and Thomas D Roper, and Timothy F Jamison
Catalytic asymmetric synthesis of an HIV integrase inhibitor.
January 2009, Organic letters,
Export Citation
×
Select Citation Style to be generated
APA
Vancouver
Harvard
BibTeX
Endnote
Generated Citation:
Selection Actions
Export Citations
Download Data
Save To My Collection
Need Help?
Explore features, get started with a guided tour, or view relevant help articles.
Start Tour
Go to Related Help Article
Copied contents to your clipboard!
Publications over Time
×
Save Item To Your Collection
×
Collection Name
Your saved publications will be grouped by this name - think of it like a folder to group related publications and results.
Use default name